This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Oct;127(4):518-25.

doi: 10.1016/s0022-3476(95)70106-0.

Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine

P R Krause¹, D M Klinman

Affiliations

PMID: 7562270
DOI: 10.1016/s0022-3476(95)70106-0

Review

Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine

P R Krause et al. J Pediatr. 1995 Oct.

. 1995 Oct;127(4):518-25.

doi: 10.1016/s0022-3476(95)70106-0.

Authors

P R Krause¹, D M Klinman

Affiliation

¹ Laboratory of DNA Viruses, Food and Drug Administration, Bethesda, MD 20892, USA.

PMID: 7562270
DOI: 10.1016/s0022-3476(95)70106-0

No abstract available

PubMed Disclaimer

Similar articles

Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
Asano Y, Nagai T, Miyata T, Yazaki T, Ito S, Yamanishi K, Takahashi M. Asano Y, et al. Biken J. 1984 Sep;27(2-3):123-8. Biken J. 1984. PMID: 6100049 No abstract available.
[Development of live varicella vaccine].
Takahashi M, Asano Y, Kamiya H, Baba K. Takahashi M, et al. Nihon Rinsho. 1985 Jul;43(7):1535-41. Nihon Rinsho. 1985. PMID: 2997506 Review. Japanese. No abstract available.
Application of a live varicella vaccine to hospitalized children and its follow-up study.
Katsushima N, Yazaki N, Sakamoto M, Fujiyama J, Nakagawa M, Okuyama Y, Takahashi M. Katsushima N, et al. Biken J. 1982 Mar;25(1):29-42. Biken J. 1982. PMID: 6289798 No abstract available.
Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
Bancillon A, Leblanc T, Baruchel A, Schaison G, Leverger G, Mallarmey D, Teuliere L. Bancillon A, et al. Nouv Rev Fr Hematol (1978). 1991;33(6):555-6. Nouv Rev Fr Hematol (1978). 1991. PMID: 1667953 Clinical Trial.
Live attenuated varicella vaccine.
Gershon AA. Gershon AA. Annu Rev Med. 1987;38:41-50. doi: 10.1146/annurev.me.38.020187.000353. Annu Rev Med. 1987. PMID: 3034136 Review.

See all similar articles

Cited by

Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015.
Wysocki J, Malecka I, Stryczynska-Kazubska J, Rampakakis E, Kuter B, Wolfson LJ. Wysocki J, et al. BMC Public Health. 2018 Mar 27;18(1):410. doi: 10.1186/s12889-018-5298-8. BMC Public Health. 2018. PMID: 29587714 Free PMC article.
Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005.
Quian J, Rüttimann R, Romero C, Dall'Orso P, Cerisola A, Breuer T, Greenberg M, Verstraeten T. Quian J, et al. Arch Dis Child. 2008 Oct;93(10):845-50. doi: 10.1136/adc.2007.126243. Epub 2008 May 2. Arch Dis Child. 2008. PMID: 18456699 Free PMC article.
Efficacy of varicella (VZV) vaccination: an update for the clinician.
Wang L, Zhu L, Zhu H. Wang L, et al. Ther Adv Vaccines. 2016 Jan;4(1-2):20-31. doi: 10.1177/2051013616655980. Epub 2016 Jan 1. Ther Adv Vaccines. 2016. PMID: 27551429 Free PMC article.
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM. Moffat JF, et al. J Virol. 1998 Feb;72(2):965-74. doi: 10.1128/JVI.72.2.965-974.1998. J Virol. 1998. PMID: 9444989 Free PMC article.
Risk factors for breakthrough varicella in healthy children.
Lim YJ, Chew FT, Tan AY, Lee BW. Lim YJ, et al. Arch Dis Child. 1998 Dec;79(6):478-80. doi: 10.1136/adc.79.6.478. Arch Dis Child. 1998. PMID: 10210990 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information